117 related articles for article (PubMed ID: 29278422)
1. Point mutation in p14
McInerney-Leo AM; Wheeler L; Sturm RA; Tan JM; Harris JE; Anderson L; Jagirdar K; Brown MA; Leo PJ; Soyer HP; Duncan EL
Br J Dermatol; 2018 Apr; 178(4):e263-e264. PubMed ID: 29278422
[No Abstract] [Full Text] [Related]
2. A germline deletion of p14(ARF) but not CDKN2A in a melanoma-neural system tumour syndrome family.
Randerson-Moor JA; Harland M; Williams S; Cuthbert-Heavens D; Sheridan E; Aveyard J; Sibley K; Whitaker L; Knowles M; Bishop JN; Bishop DT
Hum Mol Genet; 2001 Jan; 10(1):55-62. PubMed ID: 11136714
[TBL] [Abstract][Full Text] [Related]
3. Lack of inherited mutations of PTPRD in familial melanoma and melanoma-astrocytoma syndrome.
Solomon DA; Kim JS; Yang XR; Tucker MA; Goldstein AM; Samuels Y; Waldman T
Pigment Cell Melanoma Res; 2009 Aug; 22(4):489-91. PubMed ID: 19500277
[No Abstract] [Full Text] [Related]
4. A novel methionine-53-valine mutation of p16 in a hereditary melanoma kindred.
Yang G; Niendorf KB; Tsao H
J Invest Dermatol; 2004 Sep; 123(3):574-5. PubMed ID: 15304098
[TBL] [Abstract][Full Text] [Related]
5. CDKN2A point mutations D153spl(c.457G>T) and IVS2+1G>T result in aberrant splice products affecting both p16INK4a and p14ARF.
Rutter JL; Goldstein AM; Dávila MR; Tucker MA; Struewing JP
Oncogene; 2003 Jul; 22(28):4444-8. PubMed ID: 12853981
[TBL] [Abstract][Full Text] [Related]
6. CDKN2A mutations with p14 loss predisposing to multiple nerve sheath tumours, melanoma, dysplastic naevi and internal malignancies: a case series and review of the literature.
Sargen MR; Merrill SL; Chu EY; Nathanson KL
Br J Dermatol; 2016 Oct; 175(4):785-9. PubMed ID: 26876133
[TBL] [Abstract][Full Text] [Related]
7. Novel and recurrent p14 mutations in Italian familial melanoma.
Binni F; Antigoni I; De Simone P; Majore S; Silipo V; Crisi A; Amantea A; Pacchiarini D; Castori M; De Bernardo C; Catricalà C; Grammatico P
Clin Genet; 2010 Jun; 77(6):581-6. PubMed ID: 20132244
[TBL] [Abstract][Full Text] [Related]
8. CDKN2A germline splicing mutation affecting both p16(ink4) and p14(arf) RNA processing in a melanoma/neurofibroma kindred.
Petronzelli F; Sollima D; Coppola G; Martini-Neri ME; Neri G; Genuardi M
Genes Chromosomes Cancer; 2001 Aug; 31(4):398-401. PubMed ID: 11433531
[TBL] [Abstract][Full Text] [Related]
9. Screening of germline mutations in the CDKN2A and CDKN2B genes in Swedish families with hereditary cutaneous melanoma.
Platz A; Hansson J; Månsson-Brahme E; Lagerlof B; Linder S; Lundqvist E; Sevigny P; Inganäs M; Ringborg U
J Natl Cancer Inst; 1997 May; 89(10):697-702. PubMed ID: 9168184
[TBL] [Abstract][Full Text] [Related]
10. Germline mutation of ARF in a melanoma kindred.
Hewitt C; Lee Wu C; Evans G; Howell A; Elles RG; Jordan R; Sloan P; Read AP; Thakker N
Hum Mol Genet; 2002 May; 11(11):1273-9. PubMed ID: 12019208
[TBL] [Abstract][Full Text] [Related]
11. Genomic rearrangements of the CDKN2A locus are infrequent in Italian malignant melanoma families without evidence of CDKN2A/CDK4 point mutations.
Vignoli M; Scaini MC; Ghiorzo P; Sestini R; Bruno W; Menin C; Gensini F; Piazzini M; Testori A; Manoukian S; Orlando C; D'Andrea E; Bianchi-Scarrà G; Genuardi M
Melanoma Res; 2008 Dec; 18(6):431-7. PubMed ID: 19011513
[TBL] [Abstract][Full Text] [Related]
12. Multiple neurofibromas as the presenting feature of familial atypical multiple malignant melanoma (FAMMM) syndrome.
Vanneste R; Smith E; Graham G
Am J Med Genet A; 2013 Jun; 161A(6):1425-31. PubMed ID: 23613284
[TBL] [Abstract][Full Text] [Related]
13. CDKN2A and CDK4 mutation analysis in Italian melanoma-prone families: functional characterization of a novel CDKN2A germ line mutation.
Della Torre G; Pasini B; Frigerio S; Donghi R; Rovini D; Delia D; Peters G; Huot TJ; Bianchi-Scarra G; Lantieri F; Rodolfo M; Parmiani G; Pierotti MA
Br J Cancer; 2001 Sep; 85(6):836-44. PubMed ID: 11556834
[TBL] [Abstract][Full Text] [Related]
14. Novel CDKN2A mutations detected in western Swedish families with hereditary malignant melanoma.
Erlandson A; Appelqvist F; Wennberg AM; Holm J; Enerbäck C
J Invest Dermatol; 2007 Jun; 127(6):1465-7. PubMed ID: 17255954
[TBL] [Abstract][Full Text] [Related]
15. Germline CDKN2A/p16 mutations are rare in multiple primary and familial malignant melanoma in German patients.
Lukowsky A; Schäfer-Hesterberg G; Sterry W; Voit C
J Dermatol Sci; 2008 Feb; 49(2):163-5. PubMed ID: 17890059
[No Abstract] [Full Text] [Related]
16. Estimated Prevalence, Tumor Spectrum, and Neurofibromatosis Type 1-Like Phenotype of CDKN2A-Related Melanoma-Astrocytoma Syndrome.
Sargen MR; Kim J; Potjer TP; Velthuizen ME; Martir-Negron AE; Odia Y; Helgadottir H; Hatton JN; Haley JS; Thone G; Widemann BC; Gross AM; Yohe ME; Kaplan RN; Shern JF; Sundby RT; Astiazaran-Symonds E; Yang XR; Carey DJ; Tucker MA; Stewart DR; Goldstein AM
JAMA Dermatol; 2023 Oct; 159(10):1112-1118. PubMed ID: 37585199
[TBL] [Abstract][Full Text] [Related]
17. Low prevalence of germline CDKN2A and CDK4 mutations in patients with early-onset melanoma.
Tsao H; Zhang X; Kwitkiwski K; Finkelstein DM; Sober AJ; Haluska FG
Arch Dermatol; 2000 Sep; 136(9):1118-22. PubMed ID: 10987867
[TBL] [Abstract][Full Text] [Related]
18. Immunophenotypic p14 and p16 correlations with CDKN2A mutations in primary multiple and familial melanoma: An observational study.
Boşoteanu LA; Gheorghe E; Aşchie M; Cozaru GC; Deacu M; Orășanu CI; Boşoteanu M
Medicine (Baltimore); 2023 Dec; 102(51):e36756. PubMed ID: 38134090
[TBL] [Abstract][Full Text] [Related]
19. Increased melanocytic nevi and nevus density in a G-34T CDKN2A/p16 melanoma-prone pedigree.
Florell SR; Meyer LJ; Boucher KM; Grossman D; Cannon-Albright LA; Harris RM; Samlowski WE; Zone JJ; Leachman SA
J Invest Dermatol; 2008 Aug; 128(8):2122-5. PubMed ID: 18337833
[No Abstract] [Full Text] [Related]
20. Familial melanoma-astrocytoma syndrome: synchronous diffuse astrocytoma and pleomorphic xanthoastrocytoma in a patient with germline CDKN2A/B deletion and a significant family history.
Chan AK; Han SJ; Choy W; Beleford D; Aghi MK; Berger MS; Shieh JT; Bollen AW; Perry A; Phillips JJ; Butowski N; Solomon DA
Clin Neuropathol; 2017; 36(5):213-221. PubMed ID: 28699883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]